alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# Euroopa Liidu L 66/2018

| | ISSN 1977-0650 |
| --- | --- |
| Euroopa Liidu
  Teataja | L 66 |
| | |
| Eestikeelne väljaanne | Õigusaktid | 61. aastakäik8. märts 2018 |

ISSN 1977-0650

Euroopa Liidu

Teataja

L 66

Eestikeelne väljaanne

Õigusaktid

61. aastakäik8. märts 2018

---

| Sisukord | | Parandused | Lehekülg |
| --- | --- | --- | --- |
| | * | Euroopa Parlamendi ja nõukogu 28. veebruari 2018. aasta määruse (EL) 2018/302 (mis käsitleb siseturul toimuvat põhjendamatut asukohapõhist tõkestust ja muul viisil diskrimineerimist kliendi kodakondsuse, elukoha või asukoha alusel ning millega muudetakse määrusi (EÜ) nr 2006/2004 ja (EL) 2017/2394 ning direktiivi 2009/22/EÜ) parandus ( ELT L 60 I, 2.3.2018 ) | 1 |

Sisukord

Parandused

Lehekülg

*

Euroopa Parlamendi ja nõukogu 28. veebruari 2018. aasta määruse (EL) 2018/302 (mis käsitleb siseturul toimuvat põhjendamatut asukohapõhist tõkestust ja muul viisil diskrimineerimist kliendi kodakondsuse, elukoha või asukoha alusel ning millega muudetakse määrusi (EÜ) nr 2006/2004 ja (EL) 2017/2394 ning direktiivi 2009/22/EÜ) parandus ( ELT L 60 I, 2.3.2018 )

( ELT L 60 I, 2.3.2018 )

1

| ET | Aktid, mille peakiri on trükitud harilikus trükikirjas, käsitlevad põllumajandusküsimuste igapäevast korraldust ning nende kehtivusaeg on üldjuhul piiratud.
  Kõigi ülejäänud aktide pealkirjad on trükitud poolpaksus kirjas ja nende ette on märgitud tärn. |
| --- | --- |

ET

Aktid, mille peakiri on trükitud harilikus trükikirjas, käsitlevad põllumajandusküsimuste igapäevast korraldust ning nende kehtivusaeg on üldjuhul piiratud.

Kõigi ülejäänud aktide pealkirjad on trükitud poolpaksus kirjas ja nende ette on märgitud tärn.

---

Parandused

| 8.3.2018 | ET | Euroopa Liidu Teataja | L 66/1 |
| --- | --- | --- | --- |

8.3.2018

ET

Euroopa Liidu Teataja

L 66/1

---

Euroopa Parlamendi ja nõukogu 28. veebruari 2018. aasta määruse (EL) 2018/302 (mis käsitleb siseturul toimuvat põhjendamatut asukohapõhist tõkestust ja muul viisil diskrimineerimist kliendi kodakondsuse, elukoha või asukoha alusel ning millega muudetakse määrusi (EÜ) nr 2006/2004 ja (EL) 2017/2394 ning direktiivi 2009/22/EÜ) parandus

(
  Euroopa Liidu Teataja L 60 I, 2. märts 2018
  )

Lk 14 lõppsätetes

asendatakse

„
  Euroopa Parlamendi nimel

president

L. PAVLOVA

Nõukogu nimel

eesistuja

A. TAJANI
  “

järgmisega:

„
  Euroopa Parlamendi nimel

president

A. TAJANI

Nõukogu nimel

eesistuja

L. PAVLOVA
  “.

---
EXHIBIT 32

                            SECTION 906 CERTIFICATION

<PAGE>


Exhibit 32

                     CERTIFICATION OF DISCLOSURE PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection  with the  Quarterly  Report of Jointland  Development,  Inc. (the
"Company") on Form 10-QSB for the period ending March 31, 2006 as filed with the
Securities and Exchange Commission on the date hereof (the "Report") I, Kexi Xu,
Acting  Chief  Financial  Officer of the  Company,  certify,  pursuant to 18 USC
section 1350, as adopted  pursuant to section 906 of the  Sarbanes-Oxley  Act of
2002, that to the best of my knowledge and belief:

         (1) The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

         (2) The  information  contained in the Report fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.

Dated: May 25, 2006

/s/ Kexi Xu
---------------------
Kexi Xu,
Acting Chief Financial Officer


This  certification  accompanies  the  Report  pursuant  to  Section  906 of the
Sarbanes-Oxley  Act of 2002 and shall not,  except to the extent required by the
Sarbanes-Oxley  Act of 2002,  be deemed  filed by the  Company  for  purposes of
Section 18 of the Securities Exchange Act of 1934, as amended.
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

 Respondent

 v.

TODD SEAY,

 Petitioner

:

:

:

:

:

:

:

:

:

:

:

No. 694 MAL 2014

Petition for Allowance of Appeal from the

Order of the Superior Court

ORDER

PER CURIAM

AND NOW, this 11th day of February, 2015, the Petition for Allowance of Appeal

is DENIED.
#### Donald Charles ROWE, Appellant, v. The STATE of Texas, Appellee.

No. 28729.

Court of Criminal Appeals of Texas.

Jan. 23, 1957.

No attorney for appellant of record on appeal.

Leon B. Douglas, State’s Atty., Austin, for the State.

PER CURIAM.

The offense is felony theft; the punishment, two years in the penitentiary.

The record on appeal contains no statement of facts or bills of exception. All proceedings appear to be regular and nothing is presented for review. The judgment is affirmed.
#### Ex parte Samuel SPIVEY.

No. 37038.

Court of Criminal Appeals of Texas.

June 17, 1964.

*899J. Paul Pomeroy, Jr., Houston, for appellant.

Frank Briscoe, Dist. Atty., Samuel H. Robertson, Jr., and Carl E. F. Dally, Asst. Dist. Attys., Houston, and Leon B. Douglas, State’s Atty., Austin, for the State.

DICE, Commissioner.

This is an appeal from an order entered in a habeas corpus proceeding denying appellant’s application for reduction of bail in a robbery case and remanding him to custody of the sheriff of Harris County.

The record reflects that at the time of the hearing, appellant was in custody of the sheriff of Harris County in default of bail fixed by the court in the amount of $100,000, after return of an indictment in Criminal District Court No. 3 of Harris County against him and three co-defendants for the offense of robbery with firearms, said indictment being then pending against appellant and his co-defendants in Cause No. 109,587 on the docket of Criminal District Court No. 4 of Harris County.

By supplemental transcript filed herein, it is now made known that, pending appellant’s appeal from the order remanding him to custody, the indictment upon which bail was set has been, dismissed by the court upon motion of the district attorney and a new indictment returned by the grand jury in Criminal District Court No. 2 in Cause No. 110,498, charging appellant and his co-defendants with commission of the same offense.

The dismissal of the indictment renders moot the question presented relative to the amount of appellant’s bail fixed thereon.

It follows that the appeal should be dismissed.

Appellant’s right to a hearing before the trial judge upon the question of his right to bail to answer the new indictment and the amount thereof is not before us and will not be prejudiced by the dismissal of this appeal.

The appeal is dismissed.

Opinion approved by the Court.
Exhibit 32.1

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
                       AS ADOPTED PURSUANT TO SECTION 906
                                       OF
                         THE SARBANES-OXLEY ACT OF 2002

         In connection with the quarterly report of I-trax, Inc. (the "Company")
on Form 10-QSB for the period ending June 30, 2004 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Frank A. Martin,
Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.ss.1350,
as adopted pursuant toss.906 of the Sarbanes-Oxley Act of 2002, that:

         (1) The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

         (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.

/s/ Frank A. Martin
-------------------
Frank A. Martin
Chief Executive Officer

August 16, 2004


                                       40


<PAGE>
**Exhibit99.1**

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

 

AS ADOPTED PURSUANT TO

 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connectionwith the quarterly report on Form 10-Q of Genaissance Pharmaceuticals, Inc.(the “Company”) for the period ended March 31, 2003 as filed with theSecurities and Exchange Commission on the date hereof (the “Report”), theundersigned, Kevin Rakin, Chief Executive Officer of the Company, herebycertifies, pursuant to 18 U.S.C. Section 1350, that:

 

(1)  the Report fully complies with the requirements of Section 13(a)or 15(d) of the Securities Exchange Act of 1934; and

 

(2)  the information contained in the Report fairly presents, in allmaterial respects, the financial condition and results of operations of the Company.

 

 
|   |         |   |   /s/  Kevin Rakin |   |
|--------|--------------|--------|------------------------------|--------|
| Dated: | May 15, 2003 |   | Kevin Rakin                  |
|   |         |   | Chief  Executive Officer     |

 

A signedoriginal of this written statement required by Section 906 has been provided toGenaissance Pharmaceuticals, Inc. and will be retained by Genaissance Pharmaceuticals,Inc. and furnished to the Securities and Exchange Commission or its staff uponwritten request.

 

----
1

IN THE SUPERIOR COURT OF THE STATE OF DELAWARE

JANE DOE, )

)

Plaintiff, )

)

v. ) C.A. No. N17C-10-077 MMJ 

)

DR. BRUCE GROSSINGER, )

GROSSINGER NEUROPAIN )

SPECIALISTS, P.A., )

)

Defendants. )

Submitted: February 23, 2018

Decided: March 8, 2018

Upon Defendants’

Request to Determine if the Affidavit of Merit

Complies with 18 Del. C. §§ 6853(a)(1) and (c)

ORDER

Section 6853(a)(1) of title 18 of the Delaware Code provides that all 

healthcare negligence complaints must be accompanied by an affidavit of merit as 

to each defendant signed by an expert witness, accompanied by a current 

curriculum vitae of the witness, stating that there are reasonable grounds to believe 

that there has been healthcare medical negligence committed by each defendant. 

In this case, the affidavit of merit was filed under seal, as required. Pursuant 

to 18 Del. C. § 6853(d), Defendants requested in camera review of the affidavit to 
2

determine compliance with sections 6853(a)(1) and (c). The Court has reviewed 

the affidavit of merit and the accompanying curriculum vitae. The Court finds:

1. The affidavit is signed by an expert witness.

2. The affidavit is now accompanied by a current curriculum vitae.

3. The affidavit sets forth the expert’s opinion that there are reasonable 

grounds to believe that the applicable standard of care was breached by Dr. 

Grossinger.

4. The affidavit sets forth the expert’s opinion that there are reasonable 

grounds to believe that specifically enumerated breaches by Dr. Grossinger 

proximately caused the injuries claimed in the complaint. The expert does not 

opine as to any other defendant.

5. The expert witness was licensed to practice medicine as of the date of 

the affidavit.

6. In the 3 years immediately preceding the alleged negligent act, the 

expert witness was engaged in the treatment of patients and/or in the 

teaching/academic side of medicine in the fields of Neurology and Psychiatry.

7. The expert is board certified in the fields of Neurology and 

Psychiatry.

THEREFORE, the Court having reviewed in camera the affidavit of merit 

and accompanying curriculum vitae of plaintiff’s expert witness, the Court finds 
3

that the affidavit of merit now complies with sections 6853(a)(1) and (c) of title 18 

of the Delaware Code. 

IT IS SO ORDERED.
-84 -82 -80 -78 -76 -74

 36

 38

 40

★

▲

▲

▲

▲

★ ▲ ▲ ▲ ▲

 500

 1000

 1500

 500

18 12 06 00

09/26

NOAA HYSPLIT MODEL

 Backward trajectory ending at 2300 UTC 26 Sep 07

 EDAS Meteorological Data

Source

★ at 39.41 N 76.30 W Meters AGL
No. 72-1168.

#### United States *v.*Maze.

C. A. 6th Cir.

Motion of respondent for leave to proceed *in forma pauperis*and certiorari granted.
<PAGE>
 
                                  EXHIBIT 21
<PAGE>
 
                                  Exhibit 21

                      Subsidiaries of CYTOGEN Corporation

Cellcor, Inc., a Delaware corporation, is a wholly-owned subsidiary of CYTOGEN
Corporation.

CytoRad Acquisition Corp., a Delaware corporation, is a wholly-owned subsidiary
of CYTOGEN Corporation.

CYTOGEN UK Limited, a private limited company organized under the laws of the
United Kingdom, is a wholly-owned subsidiary of CYTOGEN Corporation.

Targon Corporation, a Delaware corporation, is a majority-owned subsidiary of
CYTOGEN Corporation.
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1791 Reported in Senate (RS)]

                                                       Calendar No. 445
112th CONGRESS
  2d Session
                                H. R. 1791

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           November 17, 2011

     Received; read twice and referred to the Committee on Homeland 
                   Security and Governmental Affairs

                            January 24, 2012

  Committee discharged; referred to the Committee on Environment and 
                              Public Works

                             July 10, 2012

               Reported by Mrs. Boxer, without amendment

_______________________________________________________________________

                                 AN ACT

 
  To designate the United States courthouse under construction at 101 
South United States Route 1 in Fort Pierce, Florida, as the ``Alto Lee 
                Adams, Sr., United States Courthouse''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DESIGNATION.

    The United States courthouse under construction at 101 South United 
States Route 1 in Fort Pierce, Florida, shall be known and designated 
as the ``Alto Lee Adams, Sr., United States Courthouse''.

SEC. 2. REFERENCES.

    Any reference in a law, map, regulation, document, paper, or other 
record of the United States to the United States courthouse referred to 
in section 1 shall be deemed to be a reference to the ``Alto Lee Adams, 
Sr., United States Courthouse''.
                                                       Calendar No. 445

112th CONGRESS

  2d Session

                               H. R. 1791

_______________________________________________________________________

                                 AN ACT

  To designate the United States courthouse under construction at 101 
South United States Route 1 in Fort Pierce, Florida, as the ``Alto Lee 
                Adams, Sr., United States Courthouse''.

_______________________________________________________________________

                             July 10, 2012

                       Reported without amendment
```
<PAGE>   1
                                                                      EXHIBIT 11


                        DEP CORPORATION AND SUBSIDIARIES
                      CONSOLIDATED CONDENSED STATEMENTS OF
                        COMPUTATION OF EARNINGS PER SHARE

<TABLE>
<CAPTION>
                                                     Years ended July 31,
                                         ----------------------------------------------
                                            1997             1996              1995
                                         ----------      ------------      ------------
<S>                                      <C>             <C>               <C>          
Net loss                                 $ (438,000)     $ (7,958,000)     $(26,958,000)
                                         ==========      ============      ============
 Weighted average shares outstanding      6,701,916         6,250,368         6,244,106
                                         ==========      ============      ============
Net loss per share                       $     (.07)     $      (1.27)     $      (4.32)
                                         ==========      ============      ============
</TABLE>


Fully diluted shares are not shown because there is no difference between
primary and fully diluted.


                                   Exhibit 11
EXHIBIT 31.2

SECTION 302 CERTIFICATIONS

I, Bruce E. Thomas, certify that:

1. I have reviewed this quarterly report on Form 10-Q of BOE Financial Services of Virginia, Inc.;

2. Based on my knowledge, this quarterly
report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period
covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report,
fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
registrant and we have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is
being prepared;

(b) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report
our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation and

(c) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal
quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and

5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of
registrants board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material
weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control
over financial reporting.

Date: May 15, 2007



By:

/s/ Bruce E. ThomasBruce E. ThomasSenior Vice President andChief Financial Officer
Director Compensation Summary Term Sheet


	Exhibit 10(j)


	 


	 


	1st FRANKLIN FINANCIAL CORPORATION


	Director Compensation Summary Term Sheet


	 


	Compensation to be paid to the following directors, whether or not executive officers of the Company, will be as follows: 


	 


	Name of Director

	Compensation


	 

	 


	Ben F. Cheek,. III  (Vice Chairman)

	$-  * 


	Ben F. Cheek, IV  (Chairman)

	$35,000 


	A. Roger Guimond

	$35,000 


	James H. Harris, III

	$35,000 


	John G. Sample, Jr. (Audit Committee Chairman)

	$40,000 


	C. Dean Scarborough

	$35,000 


	Keith D. Watson

	$35,000 


	 

	 


	* Note:  Ben F, Cheek, III elected not to receive any Director fees.
Exhibit 32

Certification Pursuant to Rule 13a-14(b) or 15d-14(b) of the Securities andExchange Act of 1934

	The certification set forth below is being submitted in connection with the Annual Report onForm 10-K for the year ended December 31, 2006 (the "Report") for the purpose of complyingwith Rule 13a-14(b) or Rule 15d-14(b) of the Securities Act of 1934 (the "Exchange Act")and section 1350 of Chapter 63 of Title 18 of the United States Code. 

	Ann Murtlow, President and Chief Executive Officer and Frank P. Marino, Senior Vice President andChief Financial Officer of IPALCO Enterprises, Inc. (IPALCO), each certifies that, to the best ofhis or her knowledge:

- the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act;and 
- the information contained in the Report fairly presents, in all material respects, the financialcondition and results of operations of IPALCO.
EXHIBIT 23.1






                    INDEPENDENT AUDITORS' CONSENT
                                  
                                  
                                  
                                  
We consent to the incorporation by reference in Registration Statement No.
333-08527 on Form S-3, and in Registration Statement Nos. 33-40316, 33-45615, 
33-53260, 33-50815, 33-52039, 33-60915 and 33-60921 on Form S-8 of
IPALCO Enterprises, Inc. of our report dated January 24, 1997, (February 25,
1997 as to Note 14), appearing in this Annual Report on Form 10-K of IPALCO
Enterprises, Inc. for the year ended December 31, 1996.









Deloitte & Touche LLP

Indianapolis, Indiana
February 25, 1997
#### Ex parte Iddien Reese CONNER.

No. 28773.

Court of Criminal Appeals of Texas.

Jan. 23, 1957.

No Attorney of Record on Appeal.

Howard M. Fender, Dist. Atty., Fort Worth, Grady Owen and Conrad Florence, Asst. Dist. Attys., Fort Worth, and Leon B. Douglas, State’s Atty., Austin, for the State.

DAVIDSON, Judge.

This is an extradition case.

The executive warrant of the acting governor of this state was introduced in evidence and made a prima facie case authorizing relator’s extradition. Ex parte Wagner, 158 Tex.Cr.R. 444, 256 S.W.2d 98; Ex parte Norris, 154 Tex.Cr.R. 68, 225 S.W.2d 193; Ex parte Watkins, 159 Tex.Cr.R. 14, 259 S.W.2d 215.

There was no evidence attacking the sufficiency of the extradition warrant or overcoming the prima facie case.

The judgment is affirmed.
Exhibit
32.1





CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the Amendment No. 1 toAnnual Report of Capital Gold Corporation
(the “Company”) on Form 10-K/A for the fiscal year ended July 31, 2008 as filed
with the Securities and Exchange Commission on the date hereof (the “Report”),
I, Gifford A. Dieterle, Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley
Act of 2002, that:





(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and





(2)
The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the
Company.





/s/ Gifford A. DieterleGifford
      A. DieterleChief
      Executive OfficerFebruary
      13, 2009
#### LAURIE TOLEDO *v.*WATERFORD HOTEL GROUP, INC., ET AL.

(14217)

O’Connell, Lavery and Schaller, Js.

Argued January 23

decision released March 5, 1996

*Raymond T. Trebisacci,*for the appellant (plaintiff).

*Greg Shettle,*for the appellee (named defendant).

*Cynthia J. Coccomo,*for the appellee (defendant Wellington Associates).

PER CURIAM.

The judgment is affirmed.